Survival-related Factors in HIV/AIDS Patients: A Retrospective Cohort Study from 2011 to 2019 in Kermanshah, Iran

Author:

Ghadiri Keyghobad1ORCID,Lorestani Roya Chegene1ORCID,Kazemisafa Narges2,Rostamian Mosayeb1ORCID,Akya Alisha1ORCID,Rezaeian Shahab1ORCID,Bashiri Homayoon1ORCID,Jasemi Seyed Vahid3ORCID

Affiliation:

1. Infectious Diseases Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

2. School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

3. Behavioral Disease Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran

Abstract

Introduction: Accurate evaluation of the survival rate among HIV-positive populations is pivotal for HIV management. Objective: This study aimed to investigate the survival rate and potential survival-related factors in HIV/AIDS patients from 2011 to 2019 in the city of Kermanshah in the west of Iran. Method: In this study, 915 HIV-positive patients registered by the Kermanshah Behavioral diseases counseling center, were surveyed from 2011 to 2019. By reading the patients' files, the proper data related to the survival factors were extracted and statistically analyzed. Results: Of 915 patients, 220 (24%) died. The one-year, five-year, and ten-year survival rates were 84%, 72%, and 62%, respectively. There was a significant relationship between the survival rate and many other parameters, including treatment variables, CD4+ T cell count, the way of HIV transmission, level of education, gender, and marital status. Over time, timely initiation of treatment has increased. The data also showed that HIV transmission through drug injection has decreased, while the sexual transmission of HIV has increased. Conclusions: The results showed that in recent years, due to the appropriate treatment, the survival rate of HIV patients has increased. The highest risk factor of death was for people with low CD4+ T cell count, lack of antiretroviral therapy, low level of education, male gender, and people who inject drugs. These people need more attention to get tested for HIV- related indexes and to receive proper treatment.

Publisher

Bentham Science Publishers Ltd.

Subject

Virology,Infectious Diseases

Reference56 articles.

1. Hogg R.S.; Yip B.; Chan K.J.; Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001,286(20),2568-2577

2. May MT; Vehreschild JJ; Trickey A; Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years after the start of Treatment: Collaborative Cohort Study. Clin Infect Dis 2016,15;62 12,1571-7

3. Alimohamadi Y.; Tabatabaee H.; AfsarKazerooni P, Vahedi S, Enaami M, Teimourizad A. Epidemiologic characteristics of HIV-positive patients referring to behavioral diseases consultation center in Shiraz, Iran. Med J Islam Repub Iran 2014,28(28),147

4. Yaghobi R.; HIV Infection 1992

5. Bastami F.; Zareban E.; Beiranvand A.; Vahedi S.; Effect of educational pamphlet on knowledge and attitude of non-medical students about AIDS in University of Zabol in 2008. Health Syst Rev 2012,8(6),1027-1039

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3